Trial Profile
A Study to Evaluate the Efficacy of Gemcitabine, Oxaliplatin and Capecitabine as First-line Therapy for Patients with Nonresectable Biliary Tract Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Dec 2015
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Gemcitabine (Primary) ; Oxaliplatin (Primary)
- Indications Biliary cancer
- Focus Therapeutic Use
- 15 Dec 2015 New trial record